News & Events
News articles, press releases and events Innoblative is attending
Committed to innovative surgical solutions for improved tissue coagulation and ablation, enhancing patient care.
News & Press Releases
UTMB launches feasibility study of new device used during lumpectomy procedures
The University of Texas Medical Branch (UTMB) is enrolling patients in a U.S. feasibility study evaluating the investigational SIRA radiofrequency ablation device, an innovative technology designed for use during breast‑conserving surgery. Developed by Innoblative Designs, Inc., the device is engineered
AMA Approves Category III CPT® Code for Innoblative’s SIRA® RFA Electrosurgical Device, an Adjunct for Patients Undergoing Breast Conservation Surgery
CHICAGO, March 3, 2026 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has received Category III Current Procedural Terminology (CPT®) approval from the American Medical Association (AMA) for
Innoblative Receives U.S. IDE Approval for its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, April 10, 2025 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that the U.S. Food and Drug Administration has approved its Investigational Device Exemption (IDE) application, paving the
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has initiated its first-in-human clinical experience, successfully treating a 64-year-old patient with stage II luminal A
Innoblative Designs: Revolutionizing Post-Lumpectomy Treatment
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast cancer. Developed by a team of surgeons and graduate students at Northwestern University, our SIRAT™
Innoblative Receives U.S. FDA Breakthrough Device Designation for its SIRA RFA Electrosurgical Device
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it received Breakthrough
Upcoming & Past Events
Join Us at LSI Europe ’24
When: September 16 – 20, 2024 Location: Ritz-Carlton Penha Longa Resort in Sintra, Portugal Details: LSI Europe ’24 is MedTech’s premier partnering event that will bring
Join Us at The 25th American Society of Breast Surgeons (ASBrS) 2024 Annual Meeting
When: April 10–14, 2024 Location: Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL 32821 Learn more here
Join Us at the Society of Surgical Oncology (SSO) 2024 Annual Meeting
When: Mar 20-23 2024 Location: Georgia World Congress Center, Atlanta, GA 30313 Learn more here
Join Us at NYMBCG 50TH ANNUAL BREAST CANCER SYMPOSIUM: 2024
When: Mar 2, 2024, 7:30 AM – 3:45 PM Location: New York Academy of Medicine (NYAM), 1216 Fifth Avenue, New York, New York Find out